Behind the Scenes of Amgen's Latest Options Trends
Watching BioNTech; Traders Circulating Stock Picked By Popular Retail Trading Newsletter
Wells Fargo's 'Value Equity List' – Stocks With Potential That Trade at a Discount
RBC Capital Reiterates Sector Perform on Vertex Pharmaceuticals, Maintains $431 Price Target
Vertex Pharmaceuticals Analyst Ratings
Biogen Analyst Ratings
Argenx's ADHERE Study Published In The Lancet Neurology, Showcasing VYVGART Hytrulo's Impact On Reducing CIDP Relapse And Disease Progression
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Looking Into Vertex Pharmaceuticals's Recent Short Interest
ICON Draws Bullish View at Leerink on Business Model
10 Health Care Stocks With Whale Alerts In Today's Session
UBS Maintains Neutral on BioNTech, Raises Price Target to $131
Exchange-Traded Funds, Equity Futures Slightly Higher Pre-Bell as Investors Weigh Fed Rate Cut
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of US FOMC Policy Meeting
Cantor Fitzgerald Reiterates Neutral on Regeneron Pharmaceuticals, Maintains $1015 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $70 Price Target
Gilead Sciences Analyst Ratings
DeSantis Administration Cautions Against Pfizer, Moderna MRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
BioNTech Shares Are Trading Higher B of A Securities and JP Morgan Raised Their Respective Price Targets on the Stock.